banner
PLGA agent, Chondroitin sulfate-poly(lactic-co-glycolic acid), Purity ≥95%

Cat. No.: X25-05-YM125

PLGA agent, Chondroitin sulfate-poly(lactic-co-glycolic acid), Purity ≥95%

Synonym: Poly(lactic-co-glycolic acid)-chondroitin sulfate; PLGA-chondroitin sulfate; Chondroitin sulfate-PLGA

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
PLGA-blended chondroitin sulfate (PLGA-CS) forms copolymer nanoparticles through ester linkages, combining controlled drug release with chondroitin's bioactivity.
Glycan Name
Chondroitin sulfate
Glycan Structure
The glycan structure of chondroitin sulfate (CS) is a sulfated glycosaminoglycan (GAG) composed of repeating disaccharide units. Each unit consists of: N-acetyl-D-galactosamine (GalNAc) (β1→4 linked) D-glucuronic acid (GlcA) (β1→127 linked)
Source
Chemical synthesis
Functional Group
PLGA
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Applications
Chondroitin sulfate-poly(lactic-co-glycolic acid) can be used for its potential to engineer biodegradable copolymers for sustained-release formulation development.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0